2016 Traceability Connie Jung (U.S. Food and Drug Administration) delivering a DSCSA implementation update.
2016 Traceability Attendees enjoy a networking breakfast among the seminar’s Table-Top Sponsors.
2016 Traceability The seminar provided an opportunity for attendees to learn more about HDA’s history over the last 140 years.
2016 Traceability 2016 Traceability Seminar attendees.
2016 Traceability HDA’s Perry Fri reveals the results of a manufacturer preparedness survey and discusses the organization’s Pilot Study for Saleable Returns.
2016 Traceability Attendees network during a seminar session break.
2016 Traceability Riya Cao and Julianne Jahn of LSPediA, who participated in the seminar Table-Top Exhibits.
2016 Traceability Tim Stearns (Baxter Healthcare)
2016 Traceability Julie Kuhn (H. D. Smith), Michael Mazur (Pfizer Inc.) and Brian Tarantino (Merck & Co., Inc.) participated in the HDA Pilot Study for Saleable Returns and presented pilot results.
2016 Traceability Pilot participants discuss what was learned and the next steps involved in the implementation of the 2019 saleable returns. Panelists included Jamie Hintlian (Ernst & Young LLP), Shuan Kirkpatrick (GlaxoSmithKline), Scott Mooney (McKesson Corporation), Christopher Reed (Johnson & Johnson Supply Chain) and Matt Sample (AmerisourceBergen Corporation).
2016 Traceability Ronald Bone (Ronald N. Bone Consulting LLC) moderates the “Customer Perspectives” panel, featuring retail/pharmacy community who addressed their expectations for the industry as the DSCSA is implemented.